Norway vs Slovenia: The number of people with susceptibility test result for rifampicin
Norway
98.57
in 2021
Slovenia
98.31
in 2021
Norway rank
36th
Slovenia rank
37th
The number of people with susceptibility test result for rifampicin over time
- Norway
- Slovenia
How they compare
Norway currently reports 98.57 against 98.31 in Slovenia, a difference of 0.26.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Slovenia ahead.
Norway ranks 36th and Slovenia ranks 37th of 146 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.09 | 99.58 | 4.48 | Slovenia |
| 2020s | 98.68 | 99.15 | 0.4766 | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Norway or Slovenia?
- Norway, at 98.57 against 98.31 in Slovenia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Norway and Slovenia?
- 0.26, with Norway ahead.
- How many years of comparable data are there for Norway and Slovenia?
- 5 years are reported by both, from 2017 to 2021.
- How do Norway and Slovenia rank globally for the number of people with susceptibility test result for rifampicin?
- Norway ranks 36th and Slovenia ranks 37th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.